Successful recovery of MERS CoV pneumonia in a patient with acquired immunodeficiency syndrome: A case report

Journal of Clinical Virology

Volumn 62, Issue , 2015, Pages 69-71

  Shalhoub, Sarah ^a   AlZahrani, Abdulwahab ^b   Simhairi, Raed ^b   Mushtaq, Adnan ^a  

^a KING FAHD ARMED FORCES HOSPITAL   (Saudi Arabia)

^b King Fahad Armed Forces Hospital   (Saudi Arabia)

Author keywords

HIV; Immunodeficiency; MERS; Pneumonia

Indexed keywords

ALPHA2A INTERFERON; ATAZANAVIR; BETA1A INTERFERON; COTRIMOXAZOLE; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; GANCICLOVIR; MEROPENEM; PREDNISONE; RIBAVIRIN; RITONAVIR; VALGANCICLOVIR; ANTIVIRUS AGENT; STEROID;

ADD ON THERAPY; ADULT; ARTICLE; BLOOD EXAMINATION; CASE REPORT; COLITIS; COMPUTER ASSISTED TOMOGRAPHY; CORONAVIRUS INFECTION; COUGHING; CYTOMEGALOVIRUS INFECTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPNEA; FEVER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ELISA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; LOADING DRUG DOSE; LUNG AUSCULTATION; LUNG INFILTRATE; MALE; MIDDLE AGED; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS PNEUMONIA; OXYGEN CONSUMPTION; PHYSICAL EXAMINATION; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPUTUM ANALYSIS; THORAX RADIOGRAPHY; TREATMENT OUTCOME; VIRUS PNEUMONIA; WESTERN BLOTTING; ACQUIRED IMMUNODEFICIENCY SYNDROME; COMPLICATION; CORONAVIRUS INFECTIONS; GENETICS; PNEUMONIA, VIRAL;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANTIVIRAL AGENTS; CORONAVIRUS INFECTIONS; HUMANS; MALE; MIDDLE AGED; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; PNEUMONIA, VIRAL; RADIOGRAPHY, THORACIC; STEROIDS; TREATMENT OUTCOME;

EID: 84920416675     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2014.11.030     Document Type: Article

References (12)

1. Assiri A., Al-Tawfiq J.A., Al-Rabeeah A.A., Al-Rabiah F.A., Al-Hajjar S., Al-Barrak A., et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis 2013, 13(9):752-761.
2. Corman V.M., Eckerle I., Bleicker T., Zaki A., Landt O., Eschbach-Bludau M., et al. Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction. Euro Surveill 2012, 17(39).
3. Hart B.J., Dyall J., Postnikova E., Zhou H., Kindrachuk J., Johnson R.F., et al. Interferon-beta and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays. J Gen Virol 2014, 95(Pt 3):571-577.
4. Faure E., Poissy J., Goffard A., Fournier C., Kipnis E., Titecat M., et al. Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?. PLOS ONE 2014, 9(2):e88716.
5. Weinstock D.M., Gubareva L.V., Zuccotti G. Prolonged shedding of multidrug-resistant influenza A virus in an immunocompromised patient. N Engl J Med 2003, 348(9):867-868.
6. Gooskens J., Jonges M., Claas E.C., Meijer A., Kroes A.C. Prolonged influenza virus infection during lymphocytopenia and frequent detection of drug-resistant viruses. J Infect Dis 2009, 199(10):1435-1441.
7. Hill-Cawthorne G.A., Schelenz S., Lawes M., Dervisevic S. Oseltamivir-resistant pandemic (H1N1) 2009 in patient with impaired immune system. Emerg Infect Dis 2010, 16(7):1185-1186.
8. Reyes-Terán G., de la Rosa-Zamboni D., Ormsby C. Clinical features of subjects infected with HIV and H1N1 influenza virus [abstract]. 17th Conference on Retroviruses and Opportunistic Infections 2010, #803LB. Available at: http://www.retroconference.org/2010/PDFs/803LB.pdf.
9. de Wilde A.H., Raj V.S., Oudshoorn D., Bestebroer T.M., van Nieuwkoop S., Limpens R.W., et al. MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-alpha treatment. J Gen Virol 2013, 94(Pt 8):1749-1760.
10. Falzarano D., de Wit E., Rasmussen A.L., Feldmann F., Okumura A., Scott D.P., et al. Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques. Nat Med 2013, 19(10):1313-1317.
11. Al-Tawfiq J.A., Momattin H., Dib J., Memish Z.A. Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study. Int J Infect Dis 2014, 20:42-46.
12. Taniguchi T., Takaoka A. A weak signal for strong responses: interferon-alpha/beta revisited. Nat Rev Mol Cell Biol 2001, 2(5):378-386.